Bioclinica, Inc. (BIOC) Tops Q4 EPS by 1c

February 6, 2013 7:17 AM EST Send to a Friend
Bioclinica, Inc. (NASDAQ: BIOC) reported Q4 EPS of $0.10, $0.01 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login